The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis

Andrew G Muntean1, Jiaying Tan, Kajal Sitwala

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Cancer Cell
|June 15, 2010
PubMed

Insights

The study reveals that the polymerase associated factor complex (PAFc) directly interacts with MLL fusion proteins, which is crucial for their ability to activate gene transcription and drive leukemogenesis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Epigenetics

Background:

  • Chromosomal rearrangements involving the MLL gene are common in infant acute leukemias.
  • MLL fusion proteins drive leukemogenesis through deregulated transcriptional activity, but the underlying mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the interaction between MLL fusion proteins and other cellular factors.
  • To elucidate the role of these interactions in MLL-mediated transcriptional activation and leukemogenesis.

Main Methods:

  • Co-immunoprecipitation assays to demonstrate direct interaction between MLL and PAFc.
  • RNA interference (RNAi) to knockdown PAFc expression.
  • Chromatin immunoprecipitation (ChIP) to assess MLL recruitment to target genes.
  • Functional assays assessing transcriptional activation and cellular immortalization.

Main Results:

  • MLL directly interacts with the polymerase associated factor complex (PAFc) via sequences flanking its CxxC domain.
  • PAFc enhances MLL and MLL-AF9 mediated transcriptional activation of the Hoxa9 gene.
  • Knockdown of PAFc impairs MLL fusion protein-mediated transcription and MLL recruitment to target loci.
  • Disruption of the MLL-PAFc interaction abrogates MLL-AF9 mediated cellular immortalization, a key step in leukemogenesis.

Conclusions:

  • The interaction between MLL fusion proteins and PAFc is essential for their oncogenic function.
  • PAFc plays a critical role in MLL-mediated transcriptional dysregulation and leukemogenesis.
  • Targeting the MLL-PAFc interaction may offer a therapeutic strategy for MLL-driven leukemias.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...